Related Experiment Video
Updated: Apr 30, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
Process standardization of encounter labeling to characterize ambulatory care pharmacist activity
Carly Gabriel, Clinical Pharmacist, Trisha A Miller
1UPMC Presbyterian Shadyside Department of Pharmacy, Ambulatory Services. Pittsburgh, PA.
Background:
Structured documentation of pharmacist-provided patient care activities within the electronic medical record is crucial for recording, continuity, billing, and collecting clinical outcome data. In chart notes, the encounter reason field allows multiple semistructured or free-text entries to describe the purpose for a patient interaction. Without standardization, reason entries could not be pooled for analysis without additional chart review.
Objective:
The primary aim was to increase the utility of the encounter reason field by standardizing ambulatory care pharmacist encounter labeling and provide a template for adoption across a large academic health system. The resulting structured data are intended to better characterize pharmacist activity at individual, clinic, and system levels.
Methods:
A report collected encounter reason entries for pharmacist encounters in 4 primary care settings from April to June 2022. After the review, an ambulatory care pharmacist workgroup created a procedure for entering encounter reason, requiring entry of both an indication and an action or pharmacist service. Pharmacists were trained on the new procedure in August. A post-implementation report was repeated for September-Nov 2022. Presence and description of encounter reason entries were analyzed with descriptive statistics and presented for comparison between pre- and postimplementation.
Results:
Pre-implementation, 18.6% (n = 370) of total encounters had a generic entry that did not define the visit indication or the pharmacists' activity. Post-implementation, generic entries decreased to 3.9% (n = 88). After exclusion of anticoagulation encounters, the number of encounters with no reason decreased from 26.8% (n = 252) to 12.1% (n = 123). The number of encounters, unique patients, and disease states labeled did not change significantly from pre-to post-implementation.
Conclusion:
Implementation of a procedure for labeling encounter reason allowed for more robust characterization of pharmacist services using congruent data across pharmacist practices. This approach may be useful for pharmacist practices with limited analytics resources for more sophisticated service metrics and dashboards.
More Related Videos
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Related Concept Videos
Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
Methods of Documentation I: Source-Oriented Records
In an SOR, each discipline involved in patient care maintains a separate medical record section. This record-keeping method enables easy tracking of patient progress and ensures healthcare staff have access to up-to-date information.
Key Attributes include the following:
Methods of Documentation II: POMR
Flow Sheet
Here's a closer look at the examples of flowsheets commonly used by nurses:
Graphic Sheet Documentation:
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Therapeutic Drug Monitoring: Drug Analysis Methods